Second-quarter earnings more than doubled at US
health-care product maker Johnson & Johnson, the company said Monday.
Quarterly net income was 3.8 billion dollars, or 1.3 dollars a share. The New Jersey-based company attributed the higher earnings in part to the sale of its stake in Elan Corporation.
Revenue rose 8.5 per cent to 17.8 billion dollars year-on-year. Both earnings and revenue beat Wall Street's expectations, Bloomberg news reported.
Most Popular Stories
- Tablets, Cars Drive AT&T Gains
- 2015 Mazda MX-5 Miata Is Fast and Eager
- Small Businesses Add 3 More Worries to Their List
- DOMA Tech Adding Jobs to Process VA Claims
- Apple Warns of China iCloud Attack
- Job Hunting Is Hard Work
- Tech Firms Flock to LA's 'Silicon Beach'
- Stocks Subdued After Gains Earlier in Week
- Ford, GM Expect to Report Strong Profits
- Consumer Prices Edge Up, Surprising Economists